Blog

T cells

Autolomous and Vineti form strategic partnership to deliver end to end supply chain management solutions for cell and gene therapy sector

Autolomous LTD, the market leading developer of critical manufacturing management systems for cell and gene therapies, and Vineti, a provider of leading digital enterprise platforms for cell and gene therapy supply chains, today announce a non-exclusive collaborative partnership.

Read More
August 25, 2020

OncoBay Clinical and Vineti form strategic alliance to deliver integrated clinical trial solutions and supply chain automation for cell and gene therapies

Integrated Custom-Curated IO Clinical Trial Services and Personalized Therapy Management systems to seamlessly manage advanced therapy clinical journeys for cancer...

August 17, 2020

Vineti Announces New Chief Commercial Officer

Proven biotech/pharma executive and advanced therapies pioneer Joe DePinto brings extensive commercial expertise to the industrialization of cell and gene...

August 17, 2020

Q&A: five questions for Joe DePinto

Today, Vineti is thrilled to announce that Joe DePinto has joined us as our Chief Commercial Officer. Joe is a long-time leader in...

August 11, 2020

Avobis Bio and Vineti announce strategic collaboration to support new implantable cell therapies addressing health disorders with no cure

Avobis Bio and Vineti announce strategic collaboration to support new implantable cell therapies addressing debilitating conditions NEWARK, Del. and SAN...

July 29, 2020

Vineti and EVERSANA™ form strategic alliance to advance patient-centered services and supply chain automation for regenerative medicine

Integrated Commercial Services and Personalized Therapy Management systems to seamlessly track product and patient journey SAN FRANCISCO, Calif. and CHICAGO,...

June 16, 2020

Announcing our new enterprise-grade Alliance Network — and a collaboration with Mavens — to further industrialize cell and gene therapies

Today, I’m really excited to share more progress from Vineti. We’ve launched the new Vineti Alliance Network to deliver an enterprise-grade approach...

May 20, 2020

Cardinal Health and Vineti announce collaboration to deliver integrated commercial and logistics solutions to cell and gene therapy manufacturers

DUBLIN, OHIO and SAN FRANCISCO, CA – May 20, 2020 — Cardinal Health and Vineti Inc. today announced a collaboration to...

May 5, 2020

Vineti announces new executive team members

Today, Vineti, Inc., the provider of the leading digital platform of record for personalized therapeutics, is very pleased to share...

March 18, 2020

Quality Management Systems for advanced therapies, Part 5: what does a successful QMS look like in advanced therapies?

Note: this post is the fifth, and final post, in a five-part series on Quality Management Systems (including cGMP and...

March 11, 2020

Quality Management Systems for advanced therapies, Part 4: practical tips for de-risking the critical risks in the advanced therapy supply chain

Note: this post is the fourth in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management)...

March 9, 2020

Q&A: five questions for Phil Calvin

Today, Vineti is thrilled to announce that Phil Calvin has joined Vineti as our Chief Technology Officer. A veteran technology executive at...

March 3, 2020

Quality Management Systems for advanced therapies, Part 3: a risk based approach – what does this mean for advanced therapies?

Note: this post is the third in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management)...